This invention relates generally to anellosomes and compositions and uses thereof.

This invention relates generally to compositions for making anellovectors and uses thereof.

This invention relates generally to anellosomes and compositions and uses thereof.

Methods of inducing a protective immune response against respiratory syncytial virus (RSV) and against influenza virus, without inducing a severe adverse event in human subjects are described. The methods include administering to the subjects an effective amount of an adenoviral vector encoding a recombinant RSV F polypeptide that is stabilized in a pre-fusion conformation, along with an effective amount of an influenza vaccine.

This invention relates generally to compositions for making C A Vectors and uses thereof.

The invention describes recombinant sequences and methods for producing RNAs suitable for controlling proliferation of ant species, including Solenopsis, Camponotus, Linepithema, Tapinoma, Tetramorium, and Monomorium spp.

This invention relates generally to modified anellovirus capsid proteins, anellovectors, anelloVLPs, and compositions and uses thereof.

This invention relates generally to anellovectors, anello VLPs, and compositions and uses thereof.

This invention relates generally to anellovectors, anelloVLPs, and compositions and uses thereof.

This invention relates generally to modified anellovirus capsid proteins, anellovectors, anelloVLPs, and compositions and uses thereof.